Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim

Last Updated: January 27, 2022

DrugPatentWatch Database Preview

Actavis Labs Fl Inc Company Profile

Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ACTAVIS LABS FL INC, and what generic and branded alternatives to ACTAVIS LABS FL INC drugs are available?

ACTAVIS LABS FL INC has sixty-three approved drugs.

There are five tentative approvals on ACTAVIS LABS FL INC drugs.

Summary for Actavis Labs Fl Inc
US Patents:0

Drugs and US Patents for Actavis Labs Fl Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl Inc FLUTAMIDE flutamide CAPSULE;ORAL 075820-001 Sep 18, 2001 DISCN No No ⤷  Try it Free ⤷  Try it Free
Actavis Labs Fl Inc DILTIAZEM HYDROCHLORIDE diltiazem hydrochloride TABLET, EXTENDED RELEASE;ORAL 077686-003 Mar 15, 2010 AB RX No No ⤷  Try it Free ⤷  Try it Free
Actavis Labs Fl Inc DESMOPRESSIN ACETATE desmopressin acetate TABLET;ORAL 076470-002 Jul 1, 2005 AB RX No No ⤷  Try it Free ⤷  Try it Free
Actavis Labs Fl Inc MIRTAZAPINE mirtazapine TABLET;ORAL 076336-002 Jun 20, 2003 DISCN No No ⤷  Try it Free ⤷  Try it Free
Actavis Labs Fl Inc GLIMEPIRIDE glimepiride TABLET;ORAL 076995-003 Apr 27, 2010 DISCN No No ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for ACTAVIS LABS FL INC drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.